Accessibility Menu

Stryker(FRA) SYK

Market Cap€107.94BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2006)+851%
5 Year+19%
1 Year-17%
1 Month-1%
€279.30
-0.61%
-1.70Today
Stryker last closing stock price
MetricPriceDate
Last closeEUR 278.752026-08-31
Stryker stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-0.96%EUR 281.452026-08-24
1 month-1.41%EUR 282.752026-07-31
3 month+10.16%EUR 253.052026-06-02
Year to date-7.08%EUR 300.002025-12-30
1 year-16.59%EUR 334.202025-08-29
3 year+5.47%EUR 264.302023-09-01
5 year+19.33%EUR 233.602021-09-01
Since inception+850.63%EUR 29.602006-08-17

Stryker Financials at a Glance

Market Cap

€107.94BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

€22.16K

Net Income (TTM)

€3.20K

EPS (TTM)

€8.28

P/E Ratio

33.99

Dividend

€3.00

Beta (Volatility)

-0.05 (Low)

Price

€279.30

Volume

0

Open

€279.30

Previous Close

€281.00

Daily Range

€279.30 - €279.30

52-Week Range

€238.90 - €339.40

Estimated Earnings Date

N/A

SYK News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Stryker

Stryker Corp. is a medical technology company, which engages in the provision of innovative products and services that help improve patient and healthcare outcomes. It operates under the MedSurg and Neurotechnology, and Orthopaedics and Spine segments. The MedSurg and Neurotechnology segment includes surgical equipment and navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment, intensive care disposable products, clinical communication, workflow solutions, products for the treatment of acute ischemic and hemorrhagic stroke, traditional brain, and open skull based surgical procedures, orthobiologic, and biosurgery. The Orthopaedics and Spine segment focuses on implants used in hip and knee joint replacements and trauma and extremity surgeries, and cervical, thoracolumbar, and interbody systems used in spinal injury, deformity, and degenerative therapies. The company was founded by Homer H. Stryker in 1941 and is headquartered in Kalamazoo, MI.

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

56,000

CEO

Kevin A. Lobo, MBA

Website

www.stryker.com

SYK Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

16.39%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

2.94%

Dividend Yield

1.07%

Payout Ratio

N/A

Stock Overview

Market Cap

€107.94BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

383.57M

Volume

0

Avg. Volume

146.439

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Stryker Performance Analysis

Stryker annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31EUR 17,554,187,29921.3%
20232023-12-31EUR 18,960,044,5538.0%
20242024-12-31EUR 20,888,594,88510.2%
20252025-12-31EUR 22,254,554,9356.5%
Stryker annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31EUR 5.8733.0%
20232023-12-31EUR 7.6330.0%
20242024-12-31EUR 7.18-6.0%
20252025-12-31EUR 7.443.7%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

€5.67K

+1.1%

Gross Profit

€3.75K

+1.1%

Gross Margin

66.14%

+1.1%

Market Cap

€107.94BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

€1.87

N/A

Employees

56,000

N/A

Net Income

€1.10K

+1.4%

EBITDA

€1.81K

+1.2%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

€16.48K

-0.8%

Total Debt

€13.51K

+0.9%

Accounts Receivable

€3.27K

+1.0%

Inventory

€4.83K

+1.1%

Long Term Debt

€12.71K

+1.0%

Short Term Debt

€795.07

+0.5%

Return on Assets

7.86%

+1.1%

Return on Invested Capital

8.74%

+1.1%

Free Cash Flow

€913.01

+1.1%

Operating Cash Flow

€1.09K

+1.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,684.24-0.00%
^DJIDJI
$53,254.61-0.01%
^IXICNASDAQ
$26,319.55-0.00%
BTCBitcoin
$78,890.00-0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$13.27-0.20%
NVDANvidia
$220.78+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.97+0.11%
CNHCNH Industrial
$11.83+0.01%

Questions About SYK

What is the current price of Stryker?

Stryker is trading at €279.30 per share.

What is the 52-week range for Stryker?

Over the past 52 weeks, Stryker has traded between €238.90 and €339.40.

How much debt does Stryker have?

As of the most recent reporting period, Stryker reported total debt of €13.51B.

How much cash does Stryker have on hand?

Stryker reported €2.97B in cash and cash equivalents in its most recent financial results.

What is Stryker’s dividend yield?

Stryker currently has a dividend yield of 1.07%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services